Staar Surgical Postpones Stockholders Meeting Amid Merger Talks
I'm PortAI, I can summarize articles.
Staar Surgical (STAA) has postponed its special stockholders meeting from November 6 to December 3, 2025, due to ongoing merger discussions with Alcon. The new voting eligibility record date is October 24, 2025. Analysts rate STAA stock as a Hold with a $27.00 price target, reflecting concerns over declining revenue and profitability. The company, a leader in implantable phakic intraocular lenses, faces operational challenges and a neutral technical outlook. STAAR has sold over 3 million ICLs globally and has a market cap of $1.3B.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments